+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viscosupplementation Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Area (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Viscosupplementation Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Area (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Viscosupplementation Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Area (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986027
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The viscosupplementation market is experiencing robust expansion as minimally invasive osteoarthritis treatments gain preference worldwide. Senior healthcare stakeholders are closely tracking this evolution as new technologies and regulatory developments drive demand and shape competitive dynamics.

Viscosupplementation Market Snapshot

The Viscosupplementation Market grew from USD 3.01 billion in 2024 to USD 3.20 billion in 2025. It is expected to continue growing at a CAGR of 6.22%, reaching USD 4.32 billion by 2030. This growth reflects increasing adoption of hyaluronic acid-based therapies for osteoarthritis, driven by advancements in formulation stability, targeted molecular design, and a rise in global patient awareness. The expanding role of digital health tools and telemedicine is also supporting greater market reach and improved adherence among diverse patient populations.

Scope & Segmentation of the Viscosupplementation Market

  • Product Types: Cross linked hyaluronic acid therapies, including both multiple and single injection regimens, and non cross linked hyaluronic acid products spanning low, medium, and high molecular weight offers.
  • Clinical Application Areas: Solutions targeted for ankle, hip, knee, and shoulder osteoarthritis management.
  • Distribution Channels: Hospital pharmacies, online pharmacy platforms (including mail order services and prescription portals), and retail pharmacies.
  • End Users: Home care settings (self administration or assisted), hospital-based delivery, and outpatient clinics specializing in orthopedics or rheumatology.
  • Geographic Coverage: Key markets include: Americas (with a focus on the United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—plus Canada, Mexico, Brazil, Argentina) Europe, Middle East & Africa (encompassing the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland) Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies Covered: Sanofi SA, Ferring International Center SA, Bioventus Inc., Anika Therapeutics Inc., Zimmer Biomet Holdings Inc., Teva Pharmaceutical Industries Ltd., Seikagaku Corporation, LG Chem Ltd., Smith & Nephew plc, TRB Chemedica AG.

Key Takeaways for Senior Decision-Makers

  • Viscosupplementation therapies are gaining prominence in minimally invasive orthopedic care, offering non-surgical pain management and delaying joint replacement needs.
  • Innovation in hyaluronic acid formulations, including optimized molecular weight profiles and advanced cross linking, enhances both efficacy and patient convenience.
  • Next-generation delivery mechanisms such as image-guided injections and nanocarrier-enhanced compounds support improved therapeutic accuracy and outcomes.
  • Collaborations among diagnostics, device manufacturers, and biotechnology firms foster holistic, closed-loop treatment pathways tailored to diverse osteoarthritis phenotypes.
  • Value-based reimbursement dynamics are fueling the adoption of interventions that deliver measurable functional gains and patient satisfaction.
  • Regional adoption trends reflect distinct payer landscapes, infrastructure maturity, and regulatory frameworks, impacting product launches and partnership strategies.

Tariff Impact on Market Dynamics

The introduction of United States tariffs on imported hyaluronic acid precursors and finished viscosupplementation products in 2025 has altered procurement and cost strategies. Manufacturers and distributors are pursuing domestic supplier partnerships and alternative international sources, prioritizing diversified supply chain resilience. These changes underscore the importance of agile inventory planning and compliance with continually evolving regulatory and customs classifications for biomaterials.

Viscosupplementation Market: Methodology & Data Sources

This research draws from interviews with clinical specialists, procurement professionals, and patient advocacy groups across major regions, supported by secondary reviews of peer-reviewed journals, regulatory submissions, clinical trial registries, and proprietary industry data. Data triangulation and ethical standards have been maintained throughout, ensuring findings are reliable and actionable.

Why This Report Matters

  • Supports informed investment and product development decisions through granular segmentation and coverage of key trends in viscosupplementation.
  • Enables effective market entry and growth strategies, supported by analysis of regulatory, supply chain, and regional drivers shaping the viscosupplementation market landscape.
  • Facilitates stakeholder alignment on clinical, operational, and commercial best practices to achieve measurable outcomes in osteoarthritis management.

Conclusion

Viscosupplementation is at the forefront of orthopedic and rheumatology care advancements. Market leaders can leverage differentiated platforms and data-driven insight to realize sustainable growth and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of single-injection hyaluronic acid formulations in osteoarthritis therapy
5.2. Increasing investment in crosslinked hyaluronan technologies for enhanced joint lubrication and longevity
5.3. Expansion of biosimilar viscosupplements challenging branded hyaluronic acid market exclusivity
5.4. Integration of point-of-care imaging devices for precise injection guidance in knee viscosupplementation
5.5. Emergence of combination therapies pairing hyaluronic acid with platelet-rich plasma for synergistic efficacy
5.6. Rising focus on patient-reported outcomes and quality-of-life metrics in viscosupplementation clinical trials
5.7. Development of novel thermo-responsive hydrogel carriers to improve intra-articular residence time in osteoarthritis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Viscosupplementation Market, by Product Type
8.1. Introduction
8.2. Cross Linked Hyaluronic Acid
8.2.1. Multiple Injection
8.2.2. Single Injection
8.3. Non Cross Linked Hyaluronic Acid
8.3.1. High Molecular Weight
8.3.2. Low Molecular Weight
8.3.3. Medium Molecular Weight
9. Viscosupplementation Market, by Application Area
9.1. Introduction
9.2. Ankle Osteoarthritis
9.3. Hip Osteoarthritis
9.4. Knee Osteoarthritis
9.5. Shoulder Osteoarthritis
10. Viscosupplementation Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. Mail Order Services
10.3.2. Prescription Portals
10.4. Retail Pharmacies
11. Viscosupplementation Market, by End User
11.1. Introduction
11.2. Home Care
11.2.1. Assisted Administration
11.2.2. Self Administration
11.3. Hospitals
11.4. Outpatient Clinics
11.4.1. Orthopedic Practices
11.4.2. Rheumatology Clinics
12. Americas Viscosupplementation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Viscosupplementation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Viscosupplementation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sanofi SA
15.3.2. Ferring International Center SA
15.3.3. Bioventus Inc.
15.3.4. Anika Therapeutics, Inc.
15.3.5. Zimmer Biomet Holdings, Inc.
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Seikagaku Corporation
15.3.8. LG Chem Ltd.
15.3.9. Smith & Nephew plc
15.3.10. TRB Chemedica AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VISCOSUPPLEMENTATION MARKET: RESEARCHAI
FIGURE 24. VISCOSUPPLEMENTATION MARKET: RESEARCHSTATISTICS
FIGURE 25. VISCOSUPPLEMENTATION MARKET: RESEARCHCONTACTS
FIGURE 26. VISCOSUPPLEMENTATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 116. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 117. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 118. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 119. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 120. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 121. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 128. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 129. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 130. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 134. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 135. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 136. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 137. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 138. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 139. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 226. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 227. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 228. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 229. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 230. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 231. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 240. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 241. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 244. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 245. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 246. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 247. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 248. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 249. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 258. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 277. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 280. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 281. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 282. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 283. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 284. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 285. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 292. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 293. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 294. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 295. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 298. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 299. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 300. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 301. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 302. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 303. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2024 (USD MILLION)
TABLE 312. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION A

Samples

Loading
LOADING...

Companies Mentioned

  • Sanofi SA
  • Ferring International Center SA
  • Bioventus Inc.
  • Anika Therapeutics, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Seikagaku Corporation
  • LG Chem Ltd.
  • Smith & Nephew plc
  • TRB Chemedica AG

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.32 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Viscosupplementation Market Report 2025 - Product Image

Viscosupplementation Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033 - Product Image

Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033

  • Report
  • 200 Pages
  • Global
From
Viscosupplementation Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Viscosupplementation Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Viscosupplementation - Global Strategic Business Report - Product Image

Viscosupplementation - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more - Product Image

Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more

  • Report
  • 60 Pages
  • Global
From

About the Viscosupplementation Market

Viscosupplementation is a type of orthopedic device used to treat joint pain caused by osteoarthritis. It involves injecting a gel-like substance, known as a viscosupplement, into the affected joint. The viscosupplement is designed to lubricate the joint and reduce pain and inflammation. It is typically used when other treatments, such as physical therapy and medications, have not been successful. Viscosupplementation is a relatively new technology and is becoming increasingly popular as an alternative to more invasive treatments, such as joint replacement surgery. It is generally considered to be safe and effective, with few side effects. Some of the companies in the viscosupplementation market include Zimmer Biomet, Smith & Nephew, Stryker, and DePuy Synthes. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.